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Summary 
Background: Adolescent antisocial behaviour is a major health and social problem. 
Multisystemic Therapy (MST) has reduced symptoms and offending rate in US trials, but 
non-US findings are equivocal.  
Methods: We conducted an 18-month multisite pragmatic randomised controlled superiority 
trial in England. Adolescents (aged 11–17) with moderate to severe antisocial behaviour 
received either management as usual (MAU; n=342) or 3–5 months of MST followed by 
MAU (n=342). Primary outcome was proportion of out-of-home placements. Secondary 
outcomes included offending data, service and criminal justice sector costs, participant 
wellbeing, and substance misuse, measured at baseline, 6, 12, and 18 months. We used 
logistic regression for the primary outcome and mixed-effects regression models for 
secondary outcomes. 
Outcomes: At 18 months the treatment effect for out-of-home placement was not significant 
(OR 1·25, 95% CI 0·77–2·05; p=0·37). Time to first offence was also comparable but the 
number of offences was higher for the MST group at 18 months. There were consistent short-
term symptom reductions from MST in some secondary outcomes, but no evidence of 
sustained superiority on most secondary outcomes. Conduct disorder diagnoses were reduced 
by >40% in both groups. Mean total service costs were not significantly different.  
Interpretation: The findings do not support MST over MAU as the intervention of choice 
for adolescents with moderate to severe antisocial behaviour. MST achieves some early 
symptomatic gains on parent-rated outcomes, but not those based on independent records, 
which after 12 months favour MAU.  
Funding: Department for Children, Schools and Families; Department of Health.
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Research in context 
Evidence before this study 
We undertook a systematic review to identify randomised studies of Multisystemic Therapy 
(MST) for conduct disorder. We searched Embase, MEDLINE, and PsycINFO from 
inception to December 2016 using the terms “Multisystemic Therapy” or “MST” in 
combination with 49 terms covering conduct problems, to identify relevant RCTs and 
systematic reviews of MST published in the English language. The search terms were based 
on systematic searches originally conducted in 2012 by the National Collaborating Centre for 
Mental Health for National Institute for Health and Care Excellence (NICE) guidelines. We 
identified 495 papers with relevant abstracts, and full text screening of these yielded 22 
primary randomised studies of MST for CD for inclusion. Previous reviews (eg, those for 
NICE) identified MST as a promising intervention for delinquent adolescents in reducing 
recidivism and improving individual and family pathology, mitigating this major public 
health problem; these findings justified the national rollout of MST in England and elsewhere 
in Europe. Our review, like others with similar scope, found the replicability of findings in 
some non-USA studies to be mixed, with MST failing in some reports to reduce antisocial 
behaviour more than usual services but even then often demonstrating significant economic 
advantages. 
Added value of this study 
To our knowledge, this is the only independently conducted, large-sample, community-based, 
superiority cost-effectiveness study assessing the medium-term effects and costs of MST. The 
study was conducted with the treatment developers’ full collaboration but with no 
involvement from them at any stage of data acquisition or data processing. Researchers were 
blinded to treatment condition and participants were representative of those likely to be 
referred to MST services in the UK. Treatment quality in all but one of the sites was well 
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above the carefully independently specified standard expected by the developers, and the 
majority (491, 75%) of the participants were retained; reliable data on out-of-home placement 
and offending were collected from official records even for untraced participants. No long-
term benefit of MST was found, and no evidence of superior cost-effectiveness compared 
with management as usual (MAU). There was no indication of benefit in terms of reduction 
in custodial or other out-of-home arrangements, and there was a statistically significant 
beneficial effect associated with MAU versus MST in relation to offending behaviour at 18 
months following recruitment. However, there was consistent evidence that MST brought 
about more rapid change in young people’s behaviour as rated by their parents and, to a lesser 
extent, by themselves. Post-hoc analysis pointed to early-onset problems, and association 
with delinquent peers as contraindications for MST.  
Implications of all the available evidence 
Previous evidence from the USA and some European countries had suggested that MST is a 
very promising treatment, but the question of whether MST would be similarly effective in 
the UK had not been fully investigated before this study. Our results do not provide strong 
evidence for the continued national rollout of MST in child and adolescent health and social 
services. We found no evidence that major savings would ensue from further implementation 
of the model. The substantial improvements observed in both groups reflect the effectiveness 
of routinely offered interventions for this group of young people, at least when observed via 
trial methodology. Further post-hoc analysis of differences in MAU outcomes may provide 
suggestions for rational investment and/or disinvestment in this expensive domain of service 
provision. .  
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Introduction 
Youth antisocial behaviour is a common and serious problem, with costly consequences for 
the young people, their families and wider society;1 an elevated risk of health and social 
problems;2 and a ten-fold increase in public sector costs by age 28.3 
Multisystemic Therapy (MST) is an intensive family- and home-based intervention for young 
people with serious antisocial behaviour.4 Recent high-quality, quantitative systematic 
reviews of 22 randomised controlled trials (RCTs)1,5 identified MST as a promising 
intervention for improving the prognosis of adolescent antisocial and offending behaviour, 
mitigating public health impacts, and improving individual and family morbidity. However, 
outside the USA replicability of findings has been mixed, with MST failing to reduce 
antisocial behaviour more than usual services in some studies.6-9 
A small UK-based RCT provided preliminary support for MST versus comprehensive 
targeted services delivered by Youth Offending Teams (YOTs) in reducing non-violent 
offending in the 18 months following randomisation.10 The Systemic Therapy for At Risk 
Teens (START) study was a pragmatic multicentre superiority trial in which a large 
nationally representative sample of young people with moderate to severe antisocial 
behaviour were individually randomised to MST followed by management as usual (MAU) 
or MAU alone in order to determine the value added by MST in reducing the risk of out-of-
home placements and criminal behaviour over the 18-month period following referral. The 
trial also assessed MST’s impact on family relationships, wellbeing, educational 
performance, and cost-effectiveness, and the impact of previously identified moderating 
factors (callous–unemotional (CU) traits,11 pre-adolescent onset,12 delinquent peers13) and 
hypothesized mediators (parental attitudes and discipline practices14) in the context of a full 
economic evaluation. 
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Methods 
Study design and participants 
The study design and procedures are fully described in the published trial protocol.15 (For the 
study protocol see 
http://www.ucl.ac.uk/start/START_research_protocol_v3_(Final)_05.11.2013.pdf) There 
were nine MST pilot sites in the UK with at least 12 months’ experience of running the 
programme. Young people were recruited from social services, Youth Offending Teams 
(YOTs), schools, Child and Adolescent Mental Health Services (CAMHS), and voluntary 
services; all were referred to local multi-agency panels to standardise the referral process. 
These panels identified participants’ suitability for MST (see below) and invited them for 
formal assessment. 
All participants met one of five general antisocial behaviour inclusion criteria: (1) persistent 
(weekly) and enduring (≥6 months) violent and aggressive interpersonal behaviour; (2) at 
least one conviction plus three additional warnings, reprimands, or convictions; (3) a current 
DSM-IV diagnosis of CD that had not responded to treatment; (4) a permanent school 
exclusion for antisocial behaviour; (5) a significant risk of harm to others or self; and, 
additionally, at least three severity criteria indicating past difficulties across several settings 
(appendix). Exclusion criteria were kept to a minimum (appendix). 
The MST supervisor and researcher visited proposed participants and their families to assess 
inclusion and exclusion criteria and discuss the trial, including the identification of an 
acceptable and credible MAU path. Written informed consent for randomisation was sought 
at the second visit, 3–7 days after the first, when a research assistant (RA) performed the 
baseline assessment. The study protocol was approved by the London South-East Research 
Ethics Committee (09/H1102/55). 
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Randomisation and masking 
The RA initiated a secure randomisation by telephone from the trial centre (UCL), which in 
turn communicated to the referrer and family within 24 hours. Families were randomised to 
MST or MAU by an equal allocation ratio using stochastic minimisation, balancing for 
treatment centre, sex, current age (<15 or ≥15 because of differences in CAMHS service 
provision based on Gillick competence), and age at onset of antisocial behaviour (≤11 or >11, 
representing transition to secondary school with increased exposure to psychosocial risks and 
lower controls in the school environment). RAs remained blind to treatment allocation and 
were located separately to avoid leakage of trial information. Treatment fidelity assessments 
were carried out by a geographically separate research group without access to outcomes 
information. All coding, data entry, and data cleaning were done blind to allocation. Data 
were housed by a Mental Health Research Network data warehouse separate from the 
research teams. A sample (25%) of data was double-entered to reduce the chance of entry 
errors. 
Interventions 
Multisystemic Therapy (MST) is an intensive family- and home-based intervention for young 
people with serious antisocial behaviour.4 The MST therapist works primarily with the young 
person’s caregiver to improve parenting skills, enhance family relationships, increase support 
from social networks, develop skills and resources, address communication problems, 
encourage school attendance and achievement, and reduce the young person’s association 
with delinquent peers. The intervention is tailored to each family’s specific needs, using 
techniques from cognitive–behavioural, behavioural, and strategic and structural family 
therapies. Therapists meet the family three times a week for 3–5 months, and over this period 
are available 24 hours a day, 7 days a week.  
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Programme fidelity is maintained by (1) manualised weekly group supervision with an MST 
expert designated by MST Services;16 (2) a well-developed quality assurance system17 with 
twice-yearly implementation reviews; and (3) the Therapist Adherence Measure-Revised 
(TAM-R) based on independently administered interviews with parents.18 All but one site 
averaged above criterion adherence (appendix). 
Following MST, families received MAU from YOTs, CAMHS, and social and education 
services. 
MAU was based on the best available local service(s) for the young person identified by the 
multi-agency referral panel and simply designed to be in line with current community 
practice informed by treatment guidelines offered on an as-needed basis.1,19 MAU 
interventions were multicomponent, no less resource-intensive than MST, and consistent with 
the young people’s complex mental health needs and behavioural difficulties.20 Unlike MST, 
they were not coordinated in the context of a single overarching formulation, and were 
delivered without weekly expert supervision. No attempt was made to standardise MAU. See 
appendix for details of MAU interventions and services. 
Outcomes 
Outcome assessment measures were administered at baseline and 6, 12, and 18 months 
(primary endpoint chosen as at least 1 year after end of treatment to determine whether 
treatment gains were maintained). The primary outcome, chosen by the commissioners of the 
MST service because of high costs and poor long-term outcomes,21 was the proportion of 
participants assigned to long-term (≥3 months) placement in specialist residential provision. 
We report a wide range of secondary outcomes, which reflect the diverse interests of 
Government policymakers who commissioned the investigation. To ensure comparability 
with other MST trials, antisocial behaviour was examined as time to first criminal offence 
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and the total number of offences, based on official records from the Police National 
Computer and Young Offender Information System. Further secondary outcomes were 
obtained from questionnaire measures concerning antisocial behaviour and attitudes, 
completed by parents and young people (Strengths and Difficulties Questionnaire [SDQ],22 
Inventory of Callous and Unemotional Traits23), by young people alone (Self-Report 
Delinquency Measure [SRDM], which includes a substance misuse scale,24 Antisocial Beliefs 
and Attitudes Scale,25 and Youth Materialism Scale)26, and by teachers and parents (the 
ADHD scales from the Conners Comprehensive Behaviour Rating Scales [CBRS]27). 
Intermediate outcome measures of parenting skills (Alabama Parenting Questionnaire 
[APQ]28) and family functioning (Loeber Caregiver Questionnaire,29 Family Adaptability and 
Cohesion Evaluation Scale [FACES-IV]30, Level of Expressed Emotion Questionnaire,31 and 
Conflict Tactics Scale)32 were completed by parents and/or young people, as appropriate. 
Only the Monitoring and Supervision subscale of the APQ is reported here, as it is central to 
adolescent antisocial behaviour.33 Questionnaire measures concerning young people’s and 
parental wellbeing and adjustment were completed by young people (Mood and Feelings 
Questionnaire [MFQ]34 and SDQ) and parents (SDQ, CBRS,27 and General Health 
Questionnaire [GHQ])35. 
Data on educational participation (attendance and exclusions) were obtained from the 
National Pupil Database. Psychiatric disorders were identified at baseline and at 12 months 
by the Development and Well-Being Assessment (DAWBA).36 Child IQ estimates were 
obtained using two subtests from the Wechsler Abbreviated Scale of Intelligence (WASI).37 
Two qualitative studies, to be reported separately, were also conducted with a subsample of 
families and professionals, exploring service characteristics and experiences of MST. We 
intended to use three additional questionnaires to characterise the nature and delivery of 
interventions in both the MST and MAU arms (the Expectancies Questionnaire,38 the 
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California Psychotherapy Alliance Scale,39 and the Reasons for Termination checklist)40. 
However, these measures were dropped following feedback from parents and young people 
about the burden of assessments and in consultation with the Trial Steering Committee. We 
intended to use the Child Attachment Interview to measure the quality of attachment 
relationships in a subsample of families.41 However, the young people approached expressed 
concerns about completing the interview on camera (necessary for scoring) and no data were 
collected. All measures and schedules for data collection, together with observed reliability of 
the instruments, are described in the appendix.  
Statistical analysis 
On the basis of a previous UK trial10 and official records, we anticipated that 30% of the 
MAU arm would have an out-of-home placement. We considered a reduction to 20% to be 
significant clinically and in terms of policy, and calculated that 700 participants would give 
86% power to detect this difference (two-sided significance level of 5%). To take account of 
within-therapist correlation of outcomes in the MST arm, assuming based on a previous 
study10 an intraclass correlation of 0·02 giving design effects of 1·22 in the MST arm and 1 
in the MAU arm, power would be reduced to 83%. For the primary outcome, no loss to 
follow-up was expected, so this sample size was not increased. 
Analysis was by intention to treat. The primary analyses entailed a logistic regression of out-
of-home placement status at 18 months and a Cox regression for time-to-event outcomes for 
first criminal offence. Clustering by therapist was accounted for by including a random 
therapist effect. The logistic regression model included site, number of past convictions, sex, 
and age at onset of criminal behaviour as fixed effects, and was fitted using glmer() in the R 
package lme4 with a Wald test of the effect of intervention. Secondary outcomes were 
modelled using linear mixed-effects models (for continuous outcomes) adjusting for baseline 
values, and Poisson mixed models for count variables. For longitudinal outcomes, separate 
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treatment effects for 6-, 12-, and 18-month outcomes were used, together with two 
parameters representing the linear and quadratic time-trend in the outcome. Tests of 
interaction were planned to explore whether the intervention effects differed according to (1) 
sex, (2) age, (3) referral path, and (4) severity as indicated by the presence of a criminal 
record. Further non-prespecified moderator analyses were performed. These are exploratory 
and should be interpreted with caution. 
As the primary outcome data were obtained independently of the subjects, negligible missing 
data were expected. For secondary outcomes, the analysis models used yield valid inferences 
under a missing-at-random assumption. As suggested by the Data Monitoring Committee, we 
performed a sensitivity analysis using post-baseline offending data (ie, total number of 
offences committed at each 6-month interval) as auxiliary variables in a multiple imputation 
analysis (appendix). As these made only minor differences to the results, the report is based 
on non-imputed outcomes; imputed outcomes are provided in the figures and the appendix. 
Statistical tests were deemed significant if their two-sided p value was <0·05. All analyses 
were performed in R version 3.3.0. 
For the economic analysis, the costs and cost-effectiveness of treatment arms were compared 
at 18 months in terms of the proportion of participants requiring out-of-home placements. 
The economic evaluation took a broad societal perspective, including all health, social, 
education, and non-statutory sector services, as well as costs to the criminal justice sector 
resulting from crimes committed. Data on MST contacts to enable costing of the MST 
intervention were collected directly from pilot schemes to maintain the RAs’ blindness to 
group allocation. RAs collected data on use of other services (number and duration of 
contacts) in interviews with families at baseline and at each follow-up using the Child and 
Adolescent Service Use Schedule (CA-SUS). The CA-SUS was based on previous economic 
studies in similar populations42 and was adapted for use in the present study through a review 
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of the literature and pilot testing, to ensure comprehensive coverage and face validity. Data 
were collected in the following domains: delivery of MST intervention, accommodation 
services, education services, NHS secondary care services, community-based services, use of 
prescribed medication, out-of-pocket expenses, criminal justice system contacts, and criminal 
activity. The economic analysis uses all occurrences of criminal behaviour as reported in the 
CA-SUS rather than only convictions recorded in the Police National Computer or the Young 
Offender Information System database to capture all costs associated with criminal activity. 
Unit costs for the financial year 2012–13 were applied to all resources used. The cost of MST 
was calculated using a standard micro-costing approach.43 This involved estimation of 
indirect time spent on individual cases, including preparation, meetings, telephone calls and 
supervision, as well as detailed recording of face-to-face contacts. Unit costs were calculated 
using data on salaries, employer on-costs (National Insurance and superannuation), 
conditions of service, and appropriate administrative, managerial, and capital overheads, plus 
the cost of contributions from MST Services, which included MST training, MST 
supervision, and the MST licence. Nationally applicable unit costs were applied to all other 
services, including MAU. These are outlined in detail in the appendix, along with a costing 
schema for the MST intervention. Costs in the second year were discounted by 3·5%, as 
recommended by the National Institute for Health and Care Excellence.44 Detailed 
information on the economic data and unit costs applied are provided in the appendix. For the 
cost-effectiveness analysis, we calculated incremental cost-effectiveness ratios (the difference 
in mean cost divided by the difference in mean effect) and explored uncertainty with cost-
effectiveness acceptability curves, which show the probability that MST is the optimum 
choice, for a range of possible values of willingness to pay for improvements in outcome.45 
All economic analyses were adjusted for the prespecified covariates and for baseline cost and 
outcomes, as appropriate. Complete case analysis was used, with the effect of missing data 
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explored in sensitivity analyses. A prespecified secondary economic analysis using quality-
adjusted life years measured by the three-level version of the EQ-5D46,47 was planned but an 
administrative error at the start of the trial meant that the EQ-5D was not included in the 
outcome pack, resulting in extensive missing data, and this analysis had to be abandoned. In 
addition, out-of-pocket expenses had to be excluded from the cost-effectiveness analysis 
because of poor quality of reporting (less than one-quarter of the sample provided adequate 
data to enable these expenses to be costed). 
This trial is registered with ISRCTN, number ISRCTN77132214. 
Role of the funding source 
Beyond the tender brief, funders had no role in the study design, data collection and analysis, 
or interpretation of the findings. Representatives of the funders and MST-UK were present at 
the Trial Steering Committee meetings and had the opportunity to comment on drafts of this 
paper. The corresponding author had full access to all the study data and had final 
responsibility for the decision to submit the findings for publication. 
Results 
Between February 4, 2010 and September 1, 2012, 1076 young people were referred to the 
nine multi-agency panels, the largest group from Children’s Services and then YOTs (figure 
1). Of these, 16% were inappropriate referrals for MST and a further 10% did not complete 
the referral process (4% refused to take part in the study and 6% turned down the clinical 
interventions on offer). The 684 who consented to baseline assessment and randomisation 
were clinically and demographically representative of appropriate referrals (for inclusion and 
exclusion criteria, see appendix). Of this sample, 85% was retained for 6-month assessment 
and 80% at 12 months. At the final time point more than three-quarters of those (491, 75%) 
who had not withdrawn from the study were available for assessment, with slightly fewer 
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from the MAU (234, 70%) than the MST (257, 77%) group; 91% of assessments were 
completed within 30 days of the assessment due date. 
Three direct observational points were available for nearly 85% of the families. Official 
records were available for almost the complete sample (98%) for out-of-home placements, 
criminal convictions, and educational outcomes. Client and family baseline characteristics 
and moderators are displayed in table 1. The two groups were similar except there were 
slightly more young people with ADHD diagnoses in the MST arm. Over 80% of the sample 
met ICD-10 criteria for CD. 
For the overall sample of 684 at baseline, 443 participants were identified to have persistent 
and enduring violent and aggressive interpersonal behaviour; 63 participants had at least one 
conviction plus three additional warnings, reprimands, or convictions; 531 currently met 
DSM-IV diagnosis of CD that had not responded to treatment; 179 participants had been 
permanently been excluded from school for antisocial behaviour; and 67 were at significant 
risk of harm to themselves (appendix). All 684 young people at baseline scored >65 on the 
WASI, with similar scores in the MST (mean 84·2, SD 13·2) and MAU (84·0, SD 13·2) 
groups.  
Primary and key forensic outcomes 
MST had no significant effect on the probability of out-of-home placement (12·6% vs 10·7%; 
OR 1·25, 95% CI 0·77 to 2·05; p=0·37) (table 2A), determined from a combination of 
parent-report and Local Authority computerised records. The key forensic analyses examined 
the time to first offence using a Cox proportional hazards model (table 2B). MST did not 
significantly delay the time to first offence (HR 1·06, 95% CI 0·84 to 1·33; p=0·64). The 
number of offences committed in 6-month periods after the end of the intervention, based on 
police records, are displayed in table 3. Overall, the numbers were low, with the mean 
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number of offences never exceeding 1. The Poisson mixed-effects model showed that a 
significantly higher mean number of offences were committed in the MST versus the MAU 
condition by 18 months (difference in mean number 0·65, 95% CI 0·28 to 1·02; p=0·00067). 
When violent and non-violent crimes were analysed separately, the difference was in the 
same direction, but not statistically significant. Reconviction rates cannot be reported because 
these were not reliably recorded on the databases available to the research team.  
Secondary outcomes: Antisocial behaviour and attitudes 
Further analyses of parent- and youth-reported secondary outcomes are reported in tables 4 to 
6. Graphical illustrations are displayed in the appendix for summary results and individual 
variables alongside non-prespecified subscales and analyses based on multiple imputations. 
Self-report and parent report of antisocial behaviour and attitudes (tables 4A and B) showed 
significant benefits from MST at 6 months, but mostly these were no longer significant by 12 
months. Analysis of young people’s self-ratings revealed smaller differences between the 
groups even at 6 months and no differences in self-reported behaviour on the SDQ at any 
time point. Self-reported attitudinal measures of antisociality yielded no group differences at 
any time, although CU traits were rated lower by young people in MST at 18 months. MST 
showed some benefit at 6 months on self-reported delinquency (SRDM) in terms of reduced 
volume and variety of substance misuse. Materialistic attitudes characteristic of conduct 
problems did not change significantly during the study period (table 4B). 
Information obtained from the National Pupil Database indicated that MST had no significant 
effects on exclusion from school. The odds ratios (95% CI) for 6, 12, and 18 months were 
1·00 (0·70 to 1·43), 0·93 (0·64 to 1·37), and 0·71 (0·45 to 1·13), respectively. 
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Secondary outcomes: Parenting skills and family functioning  
Parents’ reports of their own parenting behaviour (Loeber Caregiver Questionnaire and APQ 
Monitoring and Supervision subscale; table 5A) indicated increased parental support and 
involvement and reduced problems with monitoring and supervision in the MST group at 6 
months. Young people’s report on parenting behaviour on the APQ Monitoring and 
Supervision subscale or Level of Expressed Emotion (table 5A) indicated no significant 
effect of MST at any point. Parent-rated family functioning (FACES-IV) favoured the MST 
participants at 6 months, but differences were no longer significant at 18 months (table 5B). 
Parent reports of partner conflict on the CTS showed no significant group differences at any 
time point (table 5B).  
Secondary outcomes: Young people’s and parental wellbeing and adjustment 
Young people’s self-report of their emotional wellbeing on the SDQ and MFQ indicated 
statistically significant benefits from MST at 6 and 12 months but no differences at 18 
months (table 6A). Parental reports of young people’s wellbeing on the SDQ revealed some 
between-group differences but none were maintained at 18-month follow-up. On the parent-
rated Conners ADHD scale, scores were significantly higher in the MAU condition at 6 
months but not thereafter, but teachers were unable to detect this change (table 6B). Parental 
reports suggested larger effects at 6 and 12 months but these dissipated at 18 months (table 
6B). Teachers’ ratings using the other Conners behaviour rating scales (appendix) did not 
detect an impact of the MST intervention, although teachers reported less disruptive 
behaviour in the MST group at 12 months (estimate: –2·56, 95% CI –4·77 to –0·35; 
p=0·025). Parental wellbeing benefited from MST and differences on the GHQ continued to 
favour MST at 18 months post-baseline (table 6B). Clinician ratings on the DAWBA 
identified no significant between-group differences in psychiatric disorders at either baseline 
or 12 months (table 6C). 
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Moderator analyses 
We considered several potential moderators (table 2). Onset of antisocial behaviour before 11 
years powerfully moderated the effect of MST on out-of-home placements (interaction: OR 
4·95, 95% CI 1·74 to 14·0; p=0·0026). There was a significant detrimental effect of MST 
(OR 3·11, 95% CI 1·40 to 6·93; p=0·0014) in the early-onset group when directly compared 
with the late-onset group, and a non-significant beneficial effect of MST in the late-onset 
group (OR 0·63, 95% CI 0·32 to 1·23; p=0·17). 
CU traits at baseline also moderated the impact of MST on out-of-home placement 
(interaction: OR 0·95, 95% CI 0·90 to 1·00; p=0·048). MST was significantly detrimental 
relative to MAU in participants low on CU traits at baseline (those scoring below the median 
in CU traits) (OR 2·77, 95% CI 1·20 to 6·40; p=0·017). There was no significant moderating 
effect of high baseline CU traits on the MST group (OR 0·70, 95% CI 0·36 to 1·35; p=0·29). 
In participants with few delinquent peers (≤the median peer delinquency score of 3), MST 
significantly decreased the time to first offence (HR 1·47, 95% CI 1·04 to 2·09; p=0·029), 
while in the group where delinquency was more socialised, MST significantly increased the 
time to first offence (HR 0·68, 95% CI 0·50 to 0·94; p=0·020).  
Figure 2 shows Kaplan–Meier curves for each subgroup. Finally, there were no interaction 
effects with psychiatric comorbidities on these treatment outcomes. 
The high level of provision (appendix) underscores (1) the participants’ high service need and 
(2) the groups’ comparability in terms of hours of face-to-face treatment, with almost no 
differences between the conditions, notwithstanding that the MST therapist contacts were not 
included in computing MAU.  
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Economic analyses 
Total service costs and outcomes over the 18-month follow-up period are summarised in 
table 7, including a breakdown of costs by service-providing sector. The mean total costs 
over 18-month follow-up were £30,928 in the MAU group and £28,678 in the MST group; 
this difference was not statistically significant (adjusted difference –£1623, 95% CI –£7684 
to £4438; p=0·60). The cost-effectiveness acceptability curve (appendix) indicates that the 
probability that MST is cost-effective compared with MAU is low and does not rise above 
18% for a range of willingness-to-pay thresholds. 
Discussion 
We identified no long-term behavioural, mental health, social care, forensic, or educational 
benefit, nor any economic advantage, for this therapy compared with MAU by local services. 
MST may actually have worsened some of these outcomes for some young people. There was 
no evidence that MST reduces the likelihood of out-of-home placement; if anything, it was 
slightly increased, perhaps because of MST’s greater attention to young people at risk 
triggering safeguarding arrangements for these young people. It should be noted that both 
arms achieved the reduction of 20% (from the actuarial estimate of 30% to the observed 
10%) that we a priori identified as clinically significant.  
In terms of the key secondary outcome of criminal behaviours, the reduction in convictions 
achieved by MST was no better than that achieved with MAU, and some advantage for MAU 
was noted by 18 months. 
MST brought about change more rapidly than MAU, especially as noted by parents, although 
this change was no more likely to be sustained in the longer term. Parents valued MST even 
though its impact on participants dissipated by the end of the study. This may account for the 
improvements in parents’ own overall mental health and reporting of improved family 
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functioning. Overall, and compared with the young people, parents may have somewhat 
benefitted from the MST programme, and sustained change in self-reported parenting in 
combination with improved mood may turn out to bring long-term behavioural benefit; this 
will be examined by an ongoing extended follow-up of this sample. In contrast, young people 
reported little change in parenting behaviour, including failing to confirm the lasting 
reduction in inconsistent parenting reported by parents in the MST group. 
It is unclear why the young people themselves appeared less sensitive to the programme’s 
benefits. Self-rated conduct problems and delinquent behaviour decreased across both groups 
with time. There were few between-group differences in antisocial attitudes, apart from an 
unpredicted difference in CU traits at 18 months favouring MST. Measures of emotional 
wellbeing (anxiety and depression) also indicated benefit from MST for the year following 
the interventions; the group differences were small in absolute terms and fell short of mean 
differences on the MFQ usually associated with clinical significance (5 points or more) but 
the pattern was statistically robust across two measures. 
There was little indication of MST’s educational benefit from either teachers or records of 
school attendance, although there were considerable missing data. Despite earlier pilot study 
evidence suggesting that MST led to cost savings,48 in this larger economic evaluation there 
is no evidence that MST is more cost-effective than MAU. Although total costs were slightly 
lower, differences were not significant, and poorer outcomes in terms of out-of-home 
placement resulted in a low probability of MST being cost-effective compared with MAU. 
Analysis of the severity moderators yielded findings worthy of further exploration. With 
early-onset antisocial behaviour, MST appeared to increase the likelihood of costly out-of-
home placement, although it is possible that this was because close observation of family 
dynamics in MST revealed more instances where such placements were appropriate. MST 
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appeared to delay reoffending when delinquent peer influences were marked, while 
increasing risk of offending in young people without antisocial peers. MST appeared to be 
similarly detrimental relative to MAU for a low-risk group, namely low-CU individuals, 
whose time to first offence decreased following MST. The authors speculate that in relatively 
low-risk groups the focus of MST on criminal activity (eg, police involvement with acts of 
violence to family members as part of MST safety planning) may have the effect of 
enhancing adverse outcomes in individuals not previously sensitised to offending 
possibilities. 
This trial is the most comprehensive study of MST reported so far and has a number of 
strengths. It was independently conducted, with the developers’ collaboration but without 
their involvement at any stage of data acquisition or data processing. The participants were 
representative of individuals likely to be referred to MST services in the UK. We were able to 
independently assure treatment quality, all but one of the sites performed well above the 
standards expected by the developers, and no information on treatment assignment was 
available to anyone on the research team. The study retained the vast majority of participants, 
and reliable data on offending and out-of-home placement were collected for almost all 
participants. Multiple imputations using available data ensured representativeness of 
estimates where the young people, parents, or educators were unable to provide information. 
Outcomes covered the principal domains of interest, including offending; out-of-home 
placements; parent, educator, and self-rated behaviour; emotional wellbeing; family 
functioning; and societal and service costs. A putative mediator variable (parenting) was also 
incorporated. 
However, significant limitations remain. The MAU group was not a homogenous comparison 
condition, with considerable between-site variation of what was offered. Future analysis will 
reveal whether differences between services significantly influenced outcomes. MAU may 
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have offered more flexibility in addressing the young people’s specific needs, as opposed to 
MST, which focuses more on helping the family bring about behavioural change. While MST 
allows flexibility in the way specific problems are targeted, it also requires a high level of 
adherence to the interventions used, which may carry disadvantages. While the 
implementation of MST met formal fidelity criteria, the current average fidelity ratings for 
UK services significantly exceed levels achieved by these first-generation services. However, 
failures to replicate USA RCTs of interventions for youth antisocial behaviour are more 
likely due to the greater effectiveness of usual treatment rather than limitations of the UK 
implementation. A recent UK trial of Functional Family Therapy likewise found no 
improvement compared with controls, despite adequate implementation.49 We tested a large 
number of secondary outcomes, so some significant results may be attributable to multiple 
testing and, along with our moderator analyses, are best considered exploratory and requiring 
replication. While the Cronbach’s alpha (interclass reliability) coefficients were high or 
acceptable, some of the mean inter-item correlations (appendix) were outside the 0·15–0·20 
range recommended as an indication of reasonable scale internal consistency.50 
In conclusion, this rigorous and comprehensive evaluation found that MST did not 
significantly reduce dependence on MAU and brought no long-term advantages in terms of 
outcome. Although parents saw MST as bringing about more rapid and effective change, this 
was not reflected in objective indicators of delinquency. The medium-term gain from MST 
relative to MAU is limited in the behavioural domain, with some suggestion of adverse effect 
of MST in increased risk of criminal activity for individuals who are relatively low in risk in 
terms of the factors assessed in this study. 
The findings also reflect the effectiveness of UK mental health, youth offending, and social 
care services, which were active in both arms of the trial, in reducing the risk of crime and 
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protecting young people and society, at least when under the scrutiny of a randomised 
controlled trial. 
Contributors 
PF, SBu, DC, SS, SP, IE, PFu, SBy, and IMG were responsible for the original proposal, for 
securing funding for the trial, and for drafting the original protocol with assistance from EA. 
PF as chief investigator had overall responsibility for the management of the study, with 
support from SBu as clinical research lead. IMG had responsibility for the East Anglia site; 
DC and AK for the Northern site; and IE, SS, and PFu for the South-East sites. SP, PFu and 
SBu were responsible for the development of the measure of MAU interventions. RE was 
project manager throughout the trial and developed and coordinated the randomisation and 
minimisation protocol. ES was the Senior Research Assistant and supported RE with the trial 
coordination. RE (with PF and SBu) set up and coordinated the database, with all data held in 
a single repository managed by the MHRN at the East Anglia site. RE and ES coordinated 
and supervised the treatment fidelity project managed by MST Inc. JW and SBy wrote the 
statistical analysis plan. JW, PG, and SBy did the statistical analyses. RE and ES were 
responsible for data cleaning. PF wrote the initial draft of the manuscript with support from 
EA. All authors contributed to and approved the final manuscript. 
Declaration of interests 
We declare no competing interests. 
Acknowledgments 
This study received funding from the Department for Children, Schools and Families in 
conjunction with the Department of Health. Peter Fonagy is in receipt of a National Institute 
for Health Research (NIHR) Senior Investigator Award (NF-SI-0514-10157), and was in part 
supported by the NIHR Collaboration for Leadership in Applied Health Research and Care 
23 
(CLAHRC) North Thames at Barts Health NHS Trust. The views expressed are those of the 
authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Nicole 
Hickey (Imperial College London) entered, coded, analysed and prepared tables for the youth 
offending data from official records from the Police National Computer and Youth Offender 
Information System for all nine MST sites. The authors acknowledge the excellent work of 
the team of RAs involved in acquiring the data across the nine MST sites; the wise counsel of 
Professor Eric Taylor and members of the Trial Steering Committee he chaired, and of 
Professor Philip Graham and members of the Data Management and Ethics Committee he 
chaired; and the consistent and thoughtful support and oversight of Cathy James, National 
Multisystemic Therapy Programme Lead, National Implementation Service supported by 
Kathryn Harney, Associate Director of Research, Greater Manchester West Mental Health 
NHS Foundation Trust, without whom this trial could not have been completed. 
References 
1. National Institute for Health and Clinical Excellence. Conduct disorders and 
antisocial behaviour in children and young people: Recognition, intervention and 
management (CG158). London, UK: British Psychological Society and Royal College of 
Psychiatrists, 2013. 
2. Colman I, Murray J, Abbott RA, et al. Outcomes of conduct problems in adolescence: 
40 year follow-up of national cohort. BMJ 2009; 338: a2981. 
3. Khan L, Parsonage M, Stubbs J. Investing in children’s mental health: A review of 
evidence on the costs and benefits of increased service provision. London, UK: Centre for 
Mental Health, 2015. 
4. Henggeler SW, Schoenwald SK, Borduin CM, Rowland MD, Cunningham PB. 
Multisystemic therapy for antisocial behavior in children and adolescents. 2nd ed. New York: 
Guilford Press; 2009. 
5. van der Stouwe T, Asscher JJ, Stams GJ, Dekovic M, van der Laan PH. The 
effectiveness of Multisystemic Therapy (MST): a meta-analysis. Clin Psychol Rev 2014; 
34(6): 468-81. 
6. Leschied AW, Cunningham A. Seeking effective interventions for serious young 
offenders: Interim results of a four-year randomized study of multisystemic therapy in 
Ontario, Canada. London, ON: Centre for Children and Families in the Justice System, 2002. 
7. Sundell K, Hansson K, Lofholm CA, Olsson T, Gustle LH, Kadesjo C. The 
transportability of multisystemic therapy to Sweden: Short-term results from a randomized 
trial of conduct-disordered youths. J Fam Psychol 2008; 22(4): 550-60. 
8. Ogden T, Christensen B, Sheidow AJ, Holth P. Bridging the gap between science and 
practice: The effective nationwide transport of MST programs in Norway. J Child Adolesc 
Subst Abuse 2008; 17(3): 93-109. 
24 
9. Gustle LH, Hansson K, Sundell K, Andree-Lofholm C. Implementation of evidence-
based models in social work practice: practitioners' perspectives on an MST trial in Sweden. 
J Child Adolesc Subst Abuse 2008; 17(3): 111-25. 
10. Butler S, Baruch G, Hickey N, Fonagy P. A randomized controlled trial of 
multisystemic therapy and a statutory therapeutic intervention for young offenders. J Am 
Acad Child Adolesc Psychiatry 2011; 50(12): 1220-35. 
11. Wilkinson S, Waller R, Viding E. Practitioner Review: Involving young people with 
callous unemotional traits in treatment—does it work? A systematic review. J Child Psychol 
Psychiatry 2016; 57(5): 552-65. 
12. Bakker MJ, Greven CU, Buitelaar JK, Glennon JC. Practitioner Review: 
Psychological treatments for children and adolescents with conduct disorder problems – a 
systematic review and meta-analysis. J Child Psychol Psychiatry 2017; 58(1): 4-18. 
13. Dopp AR, Borduin CM, White MH, Kuppens S. Family-based treatments for serious 
juvenile offenders: A multilevel meta-analysis. J Consult Clin Psychol 2017; 85(4): 335-54. 
14. Patel CC, Fairchild AJ, Prinz RJ. Potential mediators in parenting and family 
intervention: Quality of mediation analyses. Clin Child Fam Psychol Rev 2017; 20(2): 127-
45. 
15. Fonagy P, Butler S, Goodyer I, et al. Evaluation of multisystemic therapy pilot 
services in the Systemic Therapy for At Risk Teens (START) trial: study protocol for a 
randomised controlled trial. Trials 2013; 14: 265. 
16. Strother KB, Swenson ME, Schoenwald SK. Multisystemic therapy organizational 
manual. Charleston, SC: MST Institute; 1998. 
17. Schoenwald SK, Garland AF. A review of treatment adherence measurement 
methods. Psychol Assess 2013; 25(1): 146-56. 
18. Huey SJ, Jr., Henggeler SW, Brondino MJ, Pickrel SG. Mechanisms of change in 
multisystemic therapy: reducing delinquent behavior through therapist adherence and 
improved family and peer functioning. J Consult Clin Psychol 2000; 68(3): 451-67. 
19. National Institute for Health and Clinical Excellence. Antisocial personality disorder: 
Treatment, management and prevention. London, UK: The British Psychological Society and 
the Royal College of Psychiatrists, 2010. 
20. Chitsabesan P, Kroll L, Bailey S, et al. Mental health needs of young offenders in 
custody and in the community. Br J Psychiatry 2006; 188(6): 534-40. 
21. Bazalgette L, Rahilly T, Trevelyan G. Achieving emotional wellbeing for looked after 
children. London, UK: NSPCC, 2015. 
22. Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child 
Psychol Psychiatry 1997; 38(5): 581-6. 
23. Essau CA, Sasagawa S, Frick PJ. Callous-unemotional traits in a community sample 
of adolescents. Assessment 2006; 13(4): 454-69. 
24. Smith DJ, McVie S. Theory and method in the Edinburgh study of youth transitions 
and crime. Br J Criminol 2003; 43(1): 169-95. 
25. Butler SM, Leschied AW, Fearon P. Antisocial beliefs and attitudes in pre-adolescent 
and adolescent youth: the development of the antisocial beliefs and attitudes scales (ABAS). 
J Youth Adolesc 2007; 36(8): 1058-71. 
26. Goldberg ME, Gorn GJ, Peracchio LA, Bamossy G. Understanding materialism 
among youth. J Consum Psychol 2003; 13(3): 278-88. 
27. Conners CK. Conners’ Rating Scales-Revised: technical manual. Toronto: Multi-
Health Systems; 1995. 
28. Elgar FJ, Waschbusch DA, Dadds MR, Sigvaldason N. Development and validation 
of a short form of the Alabama Parenting Questionnaire. J Child Fam Stud 2006; 16(2): 243-
59. 
25 
29. Loeber R, Stouthamer-Loeber M, Van Kammen W, Farrington DP. Initiation, 
escalation and desistance in juvenile offending and their correlates. J Crim Law Criminol 
1991; 82(1): 36-82. 
30. Olson D. FACES IV and the Circumplex Model: validation study. J Marital Fam 
Ther 2011; 37(1): 64-80. 
31. Gerlsma C, Hale WW, 3rd. Predictive power and construct validity of the Level of 
Expressed Emotion (LEE) scale. Depressed out-patients and couples from the general 
community. Br J Psychiatry 1997; 170(6): 520-5. 
32. Straus MA. Measuring intrafamily conflict and violence: the Conflict Tactics (CT) 
Scales. In: Straus MA, Gelles RJ, eds. Physical violence in American families: Risk factors 
and adaptations to violence in 8,145 families. New Brunswick, NJ: Transaction Publishing; 
1990: 403-24. 
33. Dishion TJ, McMahon RJ. Parental monitoring and the prevention of child and 
adolescent problem behavior: a conceptual and empirical formulation. Clin Child Fam 
Psychol Rev 1998; 1(1): 61-75. 
34. Messer SC, Angold A, Costello EJ, Loeber R, van Kammen W, Stouthamer-Loeber 
M. Development of a short questionnaire for use in epidemiological studies of depression in 
children and adolescents: factor composition and structure across development. Int J Methods 
Psychiatr Res 1995; 5(4): 251-62. 
35. Goldberg DP, Gater R, Sartorius N, et al. The validity of two versions of the GHQ in 
the WHO study of mental illness in general health care. Psychol Med 1997; 27(1): 191-7. 
36. Goodman R, Ford T, Richards H, Gatward R, Meltzer H. The Development and Well-
Being Assessment: Description and initial validation of an integrated assessment of child and 
adolescent psychopathology. J Child Psychol Psychiatry 2000; 41(5): 645-55. 
37. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). Oxford: Harcourt 
Assessment; 1999. 
38. Shaw BF, Elkin I, Yamaguchi J, et al. Therapist competence ratings in relation to 
clinical outcome in cognitive therapy of depression. J Consult Clin Psychol 1999; 67(6): 837-
46. 
39. Gaston L, Thompson L, Gallagher D, Cournoyer L-G, Gagnon R. Alliance, technique, 
and their interactions in predicting outcome of behavioral, cognitive, and brief dynamic 
therapy. Psychother Res 1998; 8(2): 190-209. 
40. Moras KK. Early termination and the outcome of psychotherapy: patients' 
perspectives. Diss Abstr Int 1986; 46(B): 2817-8. 
41. Shmueli-Goetz Y, Target M, Fonagy P, Datta A. The child attachment interview: A 
psychometric study of reliability and discriminant validity. Dev Psychol 2008; 44(4): 939-56. 
42. Barrett B, Byford S, Chitsabesan P, Kenning C. Mental health provision for young 
offenders: service use and cost. Br J Psychiatry 2006; 188(6): 541-6. 
43. Drummond MF, Sculpher J, Claxton K, Stoddart GL, Torrance GW. Methods for the 
economic evaluation of health care programmes. Oxford: Oxford University Press; 2015. 
44. National Institute for Health and Care Excellence. Guide to the methods of 
technology appraisal 2013. London, UK: National Institute for Health and Care Excellence, 
2013. 
45. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-
effectiveness acceptability curves. Health Econ 2001; 10(8): 779-87. 
46. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37(1): 53-72. 
47. Byford S. The validity and responsiveness of the EQ-5D measure of health-related 
quality of life in an adolescent population with persistent major depression. J Ment Health 
2013; 22(2): 101-10. 
26 
48. Cary M, Butler S, Baruch G, Hickey N, Byford S. Economic evaluation of 
multisystemic therapy for young people at risk for continuing criminal activity in the UK. 
PLoS One 2013; 8(4): e61070. 
49. Humayun S, Herlitz L, Chesnokov M, Doolan M, Landau S, Scott S. Randomized 
controlled trial of Functional Family Therapy for offending and antisocial behavior in UK 
youth. J Child Psychol Psychiatry 2017; 58(9): 1023-32. 
50. Clark LA, Watson D. Constructing validity: Basic issues in objective scale 
development. Psychol Assess 1995; 7(3): 309-19. 
  
27 
Figure captions 
 
Figure 1: Trial profile 
 
Figure 2: Time to first offence of young people with high or low levels of peer 
delinquency 
Del=peer delinquency. MAU=management as usual. MST=Multisystemic Therapy. 
 
